492 related articles for article (PubMed ID: 27128219)
1. Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.
Capitão M; Soares R
J Cell Biochem; 2016 Nov; 117(11):2443-53. PubMed ID: 27128219
[TBL] [Abstract][Full Text] [Related]
2. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy.
Behl T; Kotwani A
Pharmacol Res; 2015 Sep; 99():137-48. PubMed ID: 26054568
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema.
Fogli S; Mogavero S; Egan CG; Del Re M; Danesi R
Pharmacol Res; 2016 Jan; 103():149-57. PubMed ID: 26607863
[TBL] [Abstract][Full Text] [Related]
4. TLR7 deficiency contributes to attenuated diabetic retinopathy via inhibition of inflammatory response.
Liao YR; Li ZJ; Zeng P; Lan YQ
Biochem Biophys Res Commun; 2017 Nov; 493(2):1136-1142. PubMed ID: 28843858
[TBL] [Abstract][Full Text] [Related]
5. The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy.
Wu MY; Yiang GT; Lai TT; Li CJ
Oxid Med Cell Longev; 2018; 2018():3420187. PubMed ID: 30254714
[TBL] [Abstract][Full Text] [Related]
6. [Aging and retinal vascular diseases].
Takagi H
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin and diabetic retinopathy.
Wilkinson-Berka JL
Int J Biochem Cell Biol; 2006; 38(5-6):752-65. PubMed ID: 16165393
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.
Semeraro F; Morescalchi F; Cancarini A; Russo A; Rezzola S; Costagliola C
Diabetes Metab; 2019 Dec; 45(6):517-527. PubMed ID: 31005756
[TBL] [Abstract][Full Text] [Related]
9. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic retinopathy--the mechanisms of the ocular neovascularization and the development of anti-angiogenic drugs].
Kuroki M; Kawakami M
Nihon Rinsho; 1999 Mar; 57(3):584-9. PubMed ID: 10199138
[TBL] [Abstract][Full Text] [Related]
11. Targeting leukostasis for the treatment of early diabetic retinopathy.
Patel N
Cardiovasc Hematol Disord Drug Targets; 2009 Sep; 9(3):222-9. PubMed ID: 19619127
[TBL] [Abstract][Full Text] [Related]
12. [(Pro) renin receptor in the pathogenesis of proliferative diabetic retinopathy].
Kanda A
Nippon Ganka Gakkai Zasshi; 2014 Nov; 118(11):916-26. PubMed ID: 25543383
[TBL] [Abstract][Full Text] [Related]
13. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy.
Lai DW; Lin KH; Sheu WH; Lee MR; Chen CY; Lee WJ; Hung YW; Shen CC; Chung TJ; Liu SH; Sheu ML
Circ Res; 2017 Sep; 121(6):e37-e52. PubMed ID: 28724746
[TBL] [Abstract][Full Text] [Related]
14. [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].
Valiatti FB; Crispim D; Benfica C; Valiatti BB; Kramer CK; Canani LH
Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):106-13. PubMed ID: 21584427
[TBL] [Abstract][Full Text] [Related]
15. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
Ishida S
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
[TBL] [Abstract][Full Text] [Related]
16. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17A in diabetic retinopathy: The crosstalk of inflammation and angiogenesis.
Li J; Zhao T; Sun Y
Biochem Pharmacol; 2024 Jul; 225():116311. PubMed ID: 38788958
[TBL] [Abstract][Full Text] [Related]
18. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
19. Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?
van der Wijk AE; Hughes JM; Klaassen I; Van Noorden CJF; Schlingemann RO
J Leukoc Biol; 2017 Oct; 102(4):993-1001. PubMed ID: 28724696
[TBL] [Abstract][Full Text] [Related]
20. Growth factors in proliferative diabetic retinopathy.
Khan ZA; Chakrabarti S
Exp Diabesity Res; 2003; 4(4):287-301. PubMed ID: 14668050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
